Concerned Growth factor versus Miniral Trioide aggregate in management of Mature permanent Molar of children with irreversible pulpitis
Age range
9 Years – 16 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Clinical evaluation of cases using visual analogue scale, electrical pulp testing, Sensibility testing using both hot and cold and Percussion test for the teeth
Timeframe: 12 months
Radiographic evaluation of sucess of concentrated Growth factor versus Miniral Trioide aggregate in management of Mature permanent Molar with irreversible pulpitis
Timeframe: 12 months
Mahmoud Mostafa Abdelhakim, Master degree